SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)
ID: PAR-23-219Type: Phase II
Overview

Topic

SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)

Agency

Department of Health and Human ServicesNational Institutes of Health

Program

Type: SBIRPhase: Phase IIYear: 2023

Topic Link

https://www.sbir.gov/node/2443061

Additional Information

https://grants.nih.gov/grants/guide/PA-files/PAR-23-219.html
Timeline
  1. 1
    Release Jul 12, 2023 12:00 AM
  2. 2
    Open Aug 5, 2023 12:00 AM
  3. 3
    Next Submission Due Sep 5, 2023 12:00 AM
  4. 4
    Close Apr 6, 2025 12:00 AM
Description

The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development. This program aims to support the transition of previously funded SBIR/STTR Phase II/IIB projects to the commercialization stage by providing additional support for later stage research and development (R&D) and product development. The program is open to recipients with Phase II or IIB SBIR/STTR awards that have been active within the last 36 months. The program supports technical assistance activities such as regulatory strategy development, intellectual property strategy development, and manufacturing assistance. It also supports late stage research and development activities such as replication of key studies, optimization of manufacturing processes, and development of clinical trial supplies. The program allows for outsourcing of work to third-party technical assistance providers, but the small business should play a substantive role in the oversight and management of the R&D activities. The funding specifics and project duration can be found in the solicitation notice on grants.nih.gov.

Files
No associated files provided.
Similar Opportunities
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development. This program aims to provide additional support for later stage research and development (R&D) and product development not typically supported through Phase II or Phase IIB grants or contracts. The program is designed to bridge the funding gap between the end of the SBIR/STTR Phase II award and the commercialization stage, often referred to as the "Valley of Death." The program supports projects that require technical assistance and R&D studies that are typically outsourced to contract research organizations (CROs), such as regulatory assistance, IND/IDE enabling studies, toxicology, manufacturing, and clinical trials. The program also supports activities important for commercialization, such as product development, market planning, market research, and costs related to license agreements and partnerships. The program is open to companies that have received Phase II or Phase IIB funding from NIH within the last 36 months. The funding specifics, project duration, and performance goals can be found in the solicitation notice on grants.nih.gov.
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development. This program aims to provide additional support for later stage research and development (R&D) and product development not typically supported through Phase II or Phase IIB grants or contracts. The program is designed to bridge the funding gap between the end of the SBIR/STTR Phase II award and the commercialization stage, often referred to as the "Valley of Death." The program supports new "Type 1" applications from recipients with Phase II or IIB SBIR/STTR awards that have been active within the last 36 months. The program focuses on providing technical assistance and late stage R&D activities, such as regulatory strategy development, intellectual property strategy development, manufacturing assistance, and market research. The program also supports activities related to late stage development, including replication of key studies, optimization of manufacturing processes, animal studies, and development of clinical trial supplies. The program allows for outsourcing of work to third-party technical assistance providers, but the small business should play a substantive role in the oversight and management of the R&D activities. The program does not support clinical trials and cannot be used to pay filing fees for patents or FDA submissions. The program is open for applications until April 6, 2025, and more information can be found on the grants.gov website.
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development. This program aims to provide additional support for later stage research and development (R&D) and product development not typically supported through Phase II or Phase IIB grants or contracts. The program is designed to bridge the funding gap between the end of the SBIR/STTR Phase II award and the commercialization stage, often referred to as the "Valley of Death." The program supports projects that require technical assistance and R&D studies typically outsourced to contract research organizations (CROs), such as regulatory assistance, IND/IDE enabling studies, toxicology, manufacturing, and clinical trials. The program also supports activities important for commercialization, such as product development, market planning, market research, and costs related to license agreements and partnerships. The program is open to companies that have received Phase II or Phase IIB funding from NIH within the last 36 months. The application due dates are September 5, 2023, January 5, 2024, April 5, 2024, September 5, 2024, January 5, 2025, and April 5, 2025. For more information and to apply, visit the solicitation agency URL: [link](https://grants.nih.gov/grants/guide/PA-files/PAR-23-220.html).
Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Allowed)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the Small Business Transition Grant for Early Career Scientists. This grant aims to support early-career academic scientists interested in transitioning to entrepreneurship while also facilitating the transfer of technology from academic laboratories into small businesses. The eligibility for this grant is limited to applicants with 10 years or less of post-graduate experience. The grant allows for Phase I only Small Business Technology Transfer (STTR) applications, as well as Fast-Track applications that transition from Phase I STTR to Phase II Small Business Innovation Research (SBIR). The Phase I STTR allows for more work to be completed at the university and provides flexibility in terms of principal investigator (PI) employment. Upon successful completion of Phase I, fast-track applications transition to Phase II as an SBIR award, requiring the PI to move their employment to the small business and limiting university involvement. Mentoring is a crucial component of this grant, and a mentoring plan is required in the application. The ideal candidate for this grant is a postdoctoral researcher who has participated in technology discovery during their academic work and is ready to move to a small business with the support of an experienced team. Proposed projects must pertain to the mission space of one of the participating Institutes, including the National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering, National Human Genome Research Institute, and National Institute of Mental Health. Each Institute has specific areas of research interest, and applicants are encouraged to contact the Scientific/Research Contacts from the respective Institutes to discuss program relevance. The grant has key requirements, including the need for strong mentors, eligibility limited to early-career scientists, and alignment with the scientific/technical scope of the participating Institutes. Additionally, there are specific requirements for each Institute, such as completion of entrepreneurship training programs. The transition from Phase I to Phase II is contingent upon meeting certain criteria, including a Phase I final progress report, an updated commercialization plan, updated IP agreements, letters of support from mentors, completion of entrepreneurship programs, and verification of SBIR eligibility. The grant provides an opportunity for early-career scientists to transition to entrepreneurship and supports the advancement of technologies from academic research laboratories to small businesses.
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for SBIR Phase IIB Bridge Awards to accelerate the development of cancer-relevant technologies toward commercialization. This funding opportunity aims to support small business concerns (SBCs) that have previously received SBIR or STTR Phase II awards from any Federal agency. The goal is to assist applicants in pursuing the next milestone necessary to advance a promising product or service along a commercialization pathway. The focus is on cancer therapeutics, imaging technologies, diagnostics, prevention and control tools, and model systems for cancer research. The funding will prioritize projects that have secured substantial independent third-party investor funds and those that require approval from a Federal regulatory agency. The application due date is August 21, 2024, and more information can be found at the solicitation agency URL: [link](https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-022.html).